1,670 reports of this reaction
11.6% of all MICONAZOLE NITRATE reports
#1 most reported adverse reaction
VULVOVAGINAL BURNING SENSATION is the #1 most commonly reported adverse reaction for MICONAZOLE NITRATE, manufactured by H E B. There are 1,670 FDA adverse event reports linking MICONAZOLE NITRATE to VULVOVAGINAL BURNING SENSATION. This represents approximately 11.6% of all 14,417 adverse event reports for this drug.
Patients taking MICONAZOLE NITRATE who experience vulvovaginal burning sensation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VULVOVAGINAL BURNING SENSATION is a frequently reported adverse event for MICONAZOLE NITRATE, accounting for a significant proportion of all reports.
In addition to vulvovaginal burning sensation, the following adverse reactions have been reported for MICONAZOLE NITRATE:
The following drugs have also been linked to vulvovaginal burning sensation in FDA adverse event reports:
VULVOVAGINAL BURNING SENSATION has been reported as an adverse event in 1,670 FDA reports for MICONAZOLE NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VULVOVAGINAL BURNING SENSATION accounts for approximately 11.6% of all adverse event reports for MICONAZOLE NITRATE, making it one of the most commonly reported side effect.
If you experience vulvovaginal burning sensation while taking MICONAZOLE NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.